株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

卵巣がん診断および治療薬の世界市場 2019年~2025年

Global Ovarian Cancer Diagnostics and Therapeutics Market Size, Status and Forecast 2019-2025

発行 QYResearch 商品コード 916074
出版日 ページ情報 英文 99 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.43円で換算しております。
Back to Top
卵巣がん診断および治療薬の世界市場 2019年~2025年 Global Ovarian Cancer Diagnostics and Therapeutics Market Size, Status and Forecast 2019-2025
出版日: 2019年11月11日 ページ情報: 英文 99 Pages
概要

当レポートでは、世界の卵巣がん診断および治療薬市場を調査し、市場の概要、タイプ・用途・地域別の市場規模の推移と予測(過去5年間・今後6年間分)、企業別の収益動向、市場の成長要因および課題の分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場セグメント
  • 調査対象企業
  • 市場分析:タイプ別
    • 診断
    • 治療薬
  • 市場分析:用途別
    • 病院
    • 診療所
    • 医学研究センター
    • その他
  • 調査目的
  • 調査対象期間

第2章 世界の卵巣がん診断および治療薬市場の成長動向

  • 市場規模
  • 成長動向:地域別
  • 産業動向
    • 主要動向
    • 市場の成長要因
    • 市場の課題
    • ファイブフォース分析

第3章 卵巣がん診断および治療薬市場のシェア:企業別

  • 市場規模:企業別
    • 収益額:企業別
    • 収益シェア:企業別
    • 市場集中度
  • 主要企業の本社所在地と事業エリア
  • 主要企業の製品・ソリューション・サービス
  • 市場参入時期
  • 合併・買収・拡大計画

第4章 世界の卵巣がん診断および治療薬市場:タイプ・用途別

  • 市場規模:タイプ別
  • 市場規模:用途別

第5章 北米の卵巣がん診断および治療薬市場

  • 市場規模
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第6章 欧州の卵巣がん診断および治療薬市場

  • 市場規模
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第7章 中国の卵巣がん診断および治療薬市場

  • 市場規模
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第8章 日本の卵巣がん診断および治療薬市場

  • 市場規模
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第9章 東南アジアの卵巣がん診断および治療薬市場

  • 市場規模
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第10章 インドの卵巣がん診断および治療薬市場

  • 市場規模
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第11章 中南米の卵巣がん診断および治療薬市場

  • 市場規模
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第12章 企業プロファイル

  • Astrazeneca
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Eli Lilly
  • F. Hoffman-La Roche
  • Glaxosmithkline
  • Johnson & Johnson
  • Kazia Therapeutics
  • Siemens Healthineers
  • MSD
  • Clovis Oncology
  • Pfizer
  • Merck

第13章 市場予測

  • 市場規模の予測:タイプ別
  • 市場規模の予測:用途別
  • 市場規模の予測:地域別
  • 北米
  • 欧州
  • 中国
  • 日本
  • 東南アジア
  • インド
  • 中南米

第14章 アナリストの視点/総論

第15章 付録

  • 調査方法
  • 免責事項
  • 著者について
図表

List of Tables and Figures

  • Table Ovarian Cancer Diagnostics and Therapeutics Key Market Segments
  • Table Key Players Ovarian Cancer Diagnostics and Therapeutics Covered
  • Table Global Ovarian Cancer Diagnostics and Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
  • Figuer Diagnosis Figures
  • Table Key Players of Diagnosis
  • Figuer Therapeutics Figures
  • Table Key Players of Therapeutics
  • Table Global Ovarian Cancer Diagnostics and Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
  • Figure Global Ovarian Cancer Diagnostics and Therapeutics Market Share by Application in 2018 & 2025
  • Figure Hospital Case Studies
  • Figure Medical Research Institute Case Studies
  • Figure Pharmaceuticals Companies Case Studies
  • Figure Other Case Studies
  • Figure Ovarian Cancer Diagnostics and Therapeutics Report Years Considered
  • Figure Global Ovarian Cancer Diagnostics and Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
  • Table Global Ovarian Cancer Diagnostics and Therapeutics Market Size by Regions 2019-2025 (Million US$)
  • Table Global Ovarian Cancer Diagnostics and Therapeutics Market Size by Regions 2019-2025 (Million US$)
  • Table Global Ovarian Cancer Diagnostics and Therapeutics Market Share by Regions 2014-2019
  • Figure Global Ovarian Cancer Diagnostics and Therapeutics Market Share by Regions 2014-2019
  • Figure Global Ovarian Cancer Diagnostics and Therapeutics Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Key Drivers: Impact Analysis (2019-2025)
  • Table Key Challenges
  • Figure PORTER'S FIVE FORCES ANALYSIS
  • Table Global Ovarian Cancer Diagnostics and Therapeutics Revenue by by Players (2014-2019) (Million US$)
  • Table Global Ovarian Cancer Diagnostics and Therapeutics Market Share by by Players (2014-2019)
  • Figure Global Ovarian Cancer Diagnostics and Therapeutics Market Share by by Players in 2018
  • Table Global Ovarian Cancer Diagnostics and Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
  • Table Key Players Head office and Area Served
  • Table Key Players Ovarian Cancer Diagnostics and Therapeutics Product/Solution/Service
  • Table Date of Enter into Ovarian Cancer Diagnostics and Therapeutics Market
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Ovarian Cancer Diagnostics and Therapeutics Market Size by Type (2014-2019) (Million US$)
  • Table Global Ovarian Cancer Diagnostics and Therapeutics Market Size Share by Type (2014-2019)
  • Figure Global Ovarian Cancer Diagnostics and Therapeutics Market Size Market Share by Type (2014-2019)
  • Table Global Ovarian Cancer Diagnostics and Therapeutics Market Size by Application (2014-2019) (Million US$)
  • Table Global Ovarian Cancer Diagnostics and Therapeutics Market Size Share by Application (2014-2019)
  • Figure Global Ovarian Cancer Diagnostics and Therapeutics Market Size Market Share by Application (2014-2019)
  • Figure Global Ovarian Cancer Diagnostics and Therapeutics Revenue Market Share by Application in 2018
  • Figure North America Ovarian Cancer Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
  • Table North America Key Players Ovarian Cancer Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
  • Table North America Key Players Ovarian Cancer Diagnostics and Therapeutics Market Share (2018-2019)
  • Table North America Ovarian Cancer Diagnostics and Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table North America Ovarian Cancer Diagnostics and Therapeutics Market Share by Type 2014-2019
  • Table North America Ovarian Cancer Diagnostics and Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table North America Ovarian Cancer Diagnostics and Therapeutics Market Share by Application 2014-2019
  • Figure Europe Ovarian Cancer Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
  • Table Europe Key Players Ovarian Cancer Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
  • Table Europe Key Players Ovarian Cancer Diagnostics and Therapeutics Market Share (2018-2019)
  • Table Europe Ovarian Cancer Diagnostics and Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table Europe Ovarian Cancer Diagnostics and Therapeutics Market Share by Type 2014-2019
  • Table Europe Ovarian Cancer Diagnostics and Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table Europe Ovarian Cancer Diagnostics and Therapeutics Market Share by Application 2014-2019
  • Figure China Ovarian Cancer Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
  • Table China Key Players Ovarian Cancer Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
  • Table China Key Players Ovarian Cancer Diagnostics and Therapeutics Market Share (2018-2019)
  • Table China Ovarian Cancer Diagnostics and Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table China Ovarian Cancer Diagnostics and Therapeutics Market Share by Type 2014-2019
  • Table China Ovarian Cancer Diagnostics and Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table China Ovarian Cancer Diagnostics and Therapeutics Market Share by Application 2014-2019
  • Figure Japan Ovarian Cancer Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
  • Table Japan Key Players Ovarian Cancer Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
  • Table Japan Key Players Ovarian Cancer Diagnostics and Therapeutics Market Share (2018-2019)
  • Table Japan Ovarian Cancer Diagnostics and Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table Japan Ovarian Cancer Diagnostics and Therapeutics Market Share by Type 2014-2019
  • Table Japan Ovarian Cancer Diagnostics and Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table Japan Ovarian Cancer Diagnostics and Therapeutics Market Share by Application 2014-2019
  • Figure Southeast Asia Ovarian Cancer Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
  • Table Southeast Asia Key Players Ovarian Cancer Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
  • Table Southeast Asia Key Players Ovarian Cancer Diagnostics and Therapeutics Market Share (2018-2019)
  • Table Southeast Asia Ovarian Cancer Diagnostics and Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table Southeast Asia Ovarian Cancer Diagnostics and Therapeutics Market Share by Type 2014-2019
  • Table Southeast Asia Ovarian Cancer Diagnostics and Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table Southeast Asia Ovarian Cancer Diagnostics and Therapeutics Market Share by Application 2014-2019
  • Figure India Ovarian Cancer Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
  • Table India Key Players Ovarian Cancer Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
  • Table India Key Players Ovarian Cancer Diagnostics and Therapeutics Market Share (2018-2019)
  • Table India Ovarian Cancer Diagnostics and Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table India Ovarian Cancer Diagnostics and Therapeutics Market Share by Type 2014-2019
  • Table India Ovarian Cancer Diagnostics and Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table India Ovarian Cancer Diagnostics and Therapeutics Market Share by Application 2014-2019
  • Figure Central & South America Ovarian Cancer Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
  • Table Central & South America Key Players Ovarian Cancer Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
  • Table Central & South America Key Players Ovarian Cancer Diagnostics and Therapeutics Market Share (2018-2019)
  • Table Central & South America Ovarian Cancer Diagnostics and Therapeutics Market Size by Type 2014-2019 (Million US$)
  • Table Central & South America Ovarian Cancer Diagnostics and Therapeutics Market Share by Type 2014-2019
  • Table Central & South America Ovarian Cancer Diagnostics and Therapeutics Market Size by Application 2014-2019 (Million US$)
  • Table Central & South America Ovarian Cancer Diagnostics and Therapeutics Market Share by Application 2014-2019
  • Table Astrazeneca Company Details
  • Table Astrazeneca Revenue in Ovarian Cancer Diagnostics and Therapeutics Business 2014-2019 (Million US$)
  • Figure Astrazeneca Revenue Growth Rate in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
  • Table Astrazeneca Recent Development
  • Table Boehringer Ingelheim Company Details
  • Table Boehringer Ingelheim Revenue in Ovarian Cancer Diagnostics and Therapeutics Business 2014-2019 (Million US$)
  • Figure Boehringer Ingelheim Revenue Growth Rate in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
  • Table Boehringer Ingelheim Recent Development
  • Table Bristol Myers Squibb Company Details
  • Table Bristol Myers Squibb Revenue in Ovarian Cancer Diagnostics and Therapeutics Business 2014-2019 (Million US$)
  • Figure Bristol Myers Squibb Revenue Growth Rate in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
  • Table Bristol Myers Squibb Recent Development
  • Table Eli Lilly Company Details
  • Table Eli Lilly Revenue in Ovarian Cancer Diagnostics and Therapeutics Business 2014-2019 (Million US$)
  • Figure Eli Lilly Revenue Growth Rate in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
  • Table Eli Lilly Recent Development
  • Table F. Hoffman-La Roche Company Details
  • Table F. Hoffman-La Roche Revenue in Ovarian Cancer Diagnostics and Therapeutics Business 2014-2019 (Million US$)
  • Figure F. Hoffman-La Roche Revenue Growth Rate in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
  • Table F. Hoffman-La Roche Recent Development
  • Table Glaxosmithkline Company Details
  • Table Glaxosmithkline Revenue in Ovarian Cancer Diagnostics and Therapeutics Business 2014-2019 (Million US$)
  • Figure Glaxosmithkline Revenue Growth Rate in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
  • Table Glaxosmithkline Recent Development
  • Table Johnson & Johnson Company Details
  • Table Johnson & Johnson Revenue in Ovarian Cancer Diagnostics and Therapeutics Business 2014-2019 (Million US$)
  • Figure Johnson & Johnson Revenue Growth Rate in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
  • Table Johnson & Johnson Recent Development
  • Table Kazia Therapeutics Company Details
  • Table Kazia Therapeutics Revenue in Ovarian Cancer Diagnostics and Therapeutics Business 2014-2019 (Million US$)
  • Figure Kazia Therapeutics Revenue Growth Rate in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
  • Table Kazia Therapeutics Recent Development
  • Table Siemens Healthineers Company Details
  • Table Siemens Healthineers Revenue in Ovarian Cancer Diagnostics and Therapeutics Business 2014-2019 (Million US$)
  • Figure Siemens Healthineers Revenue Growth Rate in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
  • Table Siemens Healthineers Recent Development
  • Table MSD Company Details
  • Table MSD Revenue in Ovarian Cancer Diagnostics and Therapeutics Business 2014-2019 (Million US$)
  • Figure MSD Revenue Growth Rate in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
  • Table MSD Recent Development
  • Table Clovis Oncology Company Details
  • Table Pfizer Company Details
  • Table Merck Company Details
  • Table Global Ovarian Cancer Diagnostics and Therapeutics Market Size by Regions (Million US$) 2019-2025
  • Figure Global Ovarian Cancer Diagnostics and Therapeutics Market Size Share by Regions (2019-2025)
  • Figure Global Ovarian Cancer Diagnostics and Therapeutics Market Size Share by Regions in 2025
  • Figure North America Ovarian Cancer Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure Europe Ovarian Cancer Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure China Ovarian Cancer Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure Japan Ovarian Cancer Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure Southeast Asia Ovarian Cancer Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure India Ovarian Cancer Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Figure Central & South America Ovarian Cancer Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
  • Table Global Ovarian Cancer Diagnostics and Therapeutics Market Size by Product (2019-2025) (Million US$)
  • Figure Global Ovarian Cancer Diagnostics and Therapeutics Market Size by Product (2019-2025)
  • Figure Global Ovarian Cancer Diagnostics and Therapeutics Market Size by Product in 2025
  • Table Global Ovarian Cancer Diagnostics and Therapeutics Market Size by Application (2019-2025) (Million US$)
  • Figure Global Ovarian Cancer Diagnostics and Therapeutics Market Size by Application (2019-2025)
  • Figure Global Ovarian Cancer Diagnostics and Therapeutics Market Size by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
目次

Ovarian cancer is often fatal because it is usually advanced when diagnosed. Symptoms are usually absent in early stages and nonspecific in advanced stages.The goal of treatment for ovarian cancer is to surgically remove as much of the cancer as possible through the debulking and then to provide what is called adjuvant, or additional therapy, such as chemotherapy, to kill any possibly remaining cancer cells in the body.

In 2018, the global Ovarian Cancer Diagnostics and Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Ovarian Cancer Diagnostics and Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ovarian Cancer Diagnostics and Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

  • Astrazeneca
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Eli Lilly
  • F. Hoffman-La Roche
  • Glaxosmithkline
  • Johnson & Johnson
  • Kazia Therapeutics
  • Siemens Healthineers
  • MSD
  • Clovis Oncology
  • Pfizer
  • Merck

Market segment by Type, the product can be split into

  • Diagnosis
  • Therapeutics

Market segment by Application, split into

  • Hospital
  • Medical Research Institute
  • Pharmaceuticals Companies
  • Other

Market segment by Regions/Countries, this report covers

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global Ovarian Cancer Diagnostics and Therapeutics status, future forecast, growth opportunity, key market and key players.
  • To present the Ovarian Cancer Diagnostics and Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Ovarian Cancer Diagnostics and Therapeutics are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Ovarian Cancer Diagnostics and Therapeutics Market Size Growth Rate by Type (2014-2025)
    • 1.4.2 Diagnosis
    • 1.4.3 Therapeutics
  • 1.5 Market by Application
    • 1.5.1 Global Ovarian Cancer Diagnostics and Therapeutics Market Share by Application (2019-2025)
    • 1.5.2 Hospital
    • 1.5.3 Medical Research Institute
    • 1.5.4 Pharmaceuticals Companies
    • 1.5.5 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Ovarian Cancer Diagnostics and Therapeutics Market Size
  • 2.2 Ovarian Cancer Diagnostics and Therapeutics Growth Trends by Regions
    • 2.2.1 Ovarian Cancer Diagnostics and Therapeutics Market Size by Regions (2019-2025)
    • 2.2.2 Ovarian Cancer Diagnostics and Therapeutics Market Share by Regions (2014-2019)
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter's Five Forces Analysis

3 Market Share by Key Players

  • 3.1 Ovarian Cancer Diagnostics and Therapeutics Market Size by by Players
    • 3.1.1 Global Ovarian Cancer Diagnostics and Therapeutics Revenue by by Players (2014-2019)
    • 3.1.2 Global Ovarian Cancer Diagnostics and Therapeutics Revenue Market Share by by Players (2014-2019)
    • 3.1.3 Global Ovarian Cancer Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2 Ovarian Cancer Diagnostics and Therapeutics Key Players Head office and Area Served
  • 3.3 Key Players Ovarian Cancer Diagnostics and Therapeutics Product/Solution/Service
  • 3.4 Date of Enter into Ovarian Cancer Diagnostics and Therapeutics Market
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

  • 4.1 Global Ovarian Cancer Diagnostics and Therapeutics Market Size by Type (2014-2019)
  • 4.2 Global Ovarian Cancer Diagnostics and Therapeutics Market Size by Application (2014-2019)

5 North America

  • 5.1 North America Ovarian Cancer Diagnostics and Therapeutics Market Size (2014-2019)
  • 5.2 Ovarian Cancer Diagnostics and Therapeutics Key Players in North America
  • 5.3 North America Ovarian Cancer Diagnostics and Therapeutics Market Size by Type
  • 5.4 North America Ovarian Cancer Diagnostics and Therapeutics Market Size by Application

6 Europe

  • 6.1 Europe Ovarian Cancer Diagnostics and Therapeutics Market Size (2014-2019)
  • 6.2 Ovarian Cancer Diagnostics and Therapeutics Key Players in Europe
  • 6.3 Europe Ovarian Cancer Diagnostics and Therapeutics Market Size by Type
  • 6.4 Europe Ovarian Cancer Diagnostics and Therapeutics Market Size by Application

7 China

  • 7.1 China Ovarian Cancer Diagnostics and Therapeutics Market Size (2014-2019)
  • 7.2 Ovarian Cancer Diagnostics and Therapeutics Key Players in China
  • 7.3 China Ovarian Cancer Diagnostics and Therapeutics Market Size by Type
  • 7.4 China Ovarian Cancer Diagnostics and Therapeutics Market Size by Application

8 Japan

  • 8.1 Japan Ovarian Cancer Diagnostics and Therapeutics Market Size (2014-2019)
  • 8.2 Ovarian Cancer Diagnostics and Therapeutics Key Players in Japan
  • 8.3 Japan Ovarian Cancer Diagnostics and Therapeutics Market Size by Type
  • 8.4 Japan Ovarian Cancer Diagnostics and Therapeutics Market Size by Application

9 Southeast Asia

  • 9.1 Southeast Asia Ovarian Cancer Diagnostics and Therapeutics Market Size (2014-2019)
  • 9.2 Ovarian Cancer Diagnostics and Therapeutics Key Players in Southeast Asia
  • 9.3 Southeast Asia Ovarian Cancer Diagnostics and Therapeutics Market Size by Type
  • 9.4 Southeast Asia Ovarian Cancer Diagnostics and Therapeutics Market Size by Application

10 India

  • 10.1 India Ovarian Cancer Diagnostics and Therapeutics Market Size (2014-2019)
  • 10.2 Ovarian Cancer Diagnostics and Therapeutics Key Players in India
  • 10.3 India Ovarian Cancer Diagnostics and Therapeutics Market Size by Type
  • 10.4 India Ovarian Cancer Diagnostics and Therapeutics Market Size by Application

11 Central & South America

  • 11.1 Central & South America Ovarian Cancer Diagnostics and Therapeutics Market Size (2014-2019)
  • 11.2 Ovarian Cancer Diagnostics and Therapeutics Key Players in Central & South America
  • 11.3 Central & South America Ovarian Cancer Diagnostics and Therapeutics Market Size by Type
  • 11.4 Central & South America Ovarian Cancer Diagnostics and Therapeutics Market Size by Application

12 International Players Profiles

  • 12.1 Astrazeneca
    • 12.1.1 Astrazeneca Company Details
    • 12.1.2 Company Description and Business Overview
    • 12.1.3 Ovarian Cancer Diagnostics and Therapeutics Introduction
    • 12.1.4 Astrazeneca Revenue in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019))
    • 12.1.5 Astrazeneca Recent Development
  • 12.2 Boehringer Ingelheim
    • 12.2.1 Boehringer Ingelheim Company Details
    • 12.2.2 Company Description and Business Overview
    • 12.2.3 Ovarian Cancer Diagnostics and Therapeutics Introduction
    • 12.2.4 Boehringer Ingelheim Revenue in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
    • 12.2.5 Boehringer Ingelheim Recent Development
  • 12.3 Bristol Myers Squibb
    • 12.3.1 Bristol Myers Squibb Company Details
    • 12.3.2 Company Description and Business Overview
    • 12.3.3 Ovarian Cancer Diagnostics and Therapeutics Introduction
    • 12.3.4 Bristol Myers Squibb Revenue in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
    • 12.3.5 Bristol Myers Squibb Recent Development
  • 12.4 Eli Lilly
    • 12.4.1 Eli Lilly Company Details
    • 12.4.2 Company Description and Business Overview
    • 12.4.3 Ovarian Cancer Diagnostics and Therapeutics Introduction
    • 12.4.4 Eli Lilly Revenue in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
    • 12.4.5 Eli Lilly Recent Development
  • 12.5 F. Hoffman-La Roche
    • 12.5.1 F. Hoffman-La Roche Company Details
    • 12.5.2 Company Description and Business Overview
    • 12.5.3 Ovarian Cancer Diagnostics and Therapeutics Introduction
    • 12.5.4 F. Hoffman-La Roche Revenue in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
    • 12.5.5 F. Hoffman-La Roche Recent Development
  • 12.6 Glaxosmithkline
    • 12.6.1 Glaxosmithkline Company Details
    • 12.6.2 Company Description and Business Overview
    • 12.6.3 Ovarian Cancer Diagnostics and Therapeutics Introduction
    • 12.6.4 Glaxosmithkline Revenue in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
    • 12.6.5 Glaxosmithkline Recent Development
  • 12.7 Johnson & Johnson
    • 12.7.1 Johnson & Johnson Company Details
    • 12.7.2 Company Description and Business Overview
    • 12.7.3 Ovarian Cancer Diagnostics and Therapeutics Introduction
    • 12.7.4 Johnson & Johnson Revenue in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
    • 12.7.5 Johnson & Johnson Recent Development
  • 12.8 Kazia Therapeutics
    • 12.8.1 Kazia Therapeutics Company Details
    • 12.8.2 Company Description and Business Overview
    • 12.8.3 Ovarian Cancer Diagnostics and Therapeutics Introduction
    • 12.8.4 Kazia Therapeutics Revenue in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
    • 12.8.5 Kazia Therapeutics Recent Development
  • 12.9 Siemens Healthineers
    • 12.9.1 Siemens Healthineers Company Details
    • 12.9.2 Company Description and Business Overview
    • 12.9.3 Ovarian Cancer Diagnostics and Therapeutics Introduction
    • 12.9.4 Siemens Healthineers Revenue in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
    • 12.9.5 Siemens Healthineers Recent Development
  • 12.10 MSD
    • 12.10.1 MSD Company Details
    • 12.10.2 Company Description and Business Overview
    • 12.10.3 Ovarian Cancer Diagnostics and Therapeutics Introduction
    • 12.10.4 MSD Revenue in Ovarian Cancer Diagnostics and Therapeutics Business (2014-2019)
    • 12.10.5 MSD Recent Development
  • 12.11 Clovis Oncology
  • 12.12 Pfizer
  • 12.13 Merck

13 Market Forecast 2019-2025

  • 13.1 Market Size Forecast by Product (2019-2025)
  • 13.2 Market Size Forecast by Application (2019-2025)
  • 13.3 Market Size Forecast by Regions
  • 13.4 North America
  • 13.5 Europe
  • 13.6 China
  • 13.7 Japan
  • 13.8 Southeast Asia
  • 13.9 India
  • 13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 15.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Disclaimer
  • 15.3 Author Details
Back to Top